Treatment of Cervical Stricture in Postmenopausal or GnRH-Analog-Treated Patients When Office Hysteroscopic Adhesiolysis Has Not Restored Patency

Clinical Scenario

This protocol addresses stricture and stenosis of the cervix uteri in patients with postmenopausal status or treatment with gonadotropin-releasing hormone (GnRH) analogs — a hypoestrogenic state. In this population, the reduced estrogenic environment limits the effectiveness of standard cervical ripening approaches, making management of cervical stenosis more challenging.

Escalation Trigger — Previous Line Did Not Achieve the Goal

The first-line office hysteroscopic adhesiolysis procedure — encompassing techniques adapted to the type and degree of adhesions — did not achieve the required clinical objective:

Successful access to the uterine cavity with restored patency of the cervical canal

Next-Step Approach

When outpatient office procedures have failed to restore access to the uterine cavity, a resectoscopic surgical approach provides the pathway for the next management step in this scenario.

The complete technique, procedural sequence, and full evidence-based regimen are available in the structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

In postmenopausal women and those treated with gonadotropin-releasing hormone analogs, misoprostol has a decreased effect since prostaglandins require estrogen to generate their cervical ripening effects, and postmenopausal patients are in a hypoestrogenic state.

To date, the standard resectoscopic approach is reserved only for cases where outpatient treatment fails. The narrow cervical canal can be entered using the 26 Fr resectoscope.

The main objective of both medical and surgical treatments for cervical stenosis is to restore the patency of the cervical canal.

DOI: 10.1007/s00404-023-07126-1

View source ↗